Luminal Breast Cancer

• CLINICAL_TRIALS trial_result · 2024-12-13
  Clinical Trial Update: Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

  This clinical trial update provides extended overall survival data from the PARSIFAL study (PARSIFAL-LONG) in metastatic/advanced breast can…

• CLINICAL_TRIALS trial_result · 2024-11-20
  Clinical Trial Update: Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. [Phase 1, Phase 2]

  Phase 1/2 trial evaluating safety and efficacy of durvalumab in combination with neoadjuvant chemotherapy for localized Luminal B HER2-negat…

• CLINICAL_TRIALS trial_result · 2024-08-02
  Clinical Trial Update: Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole [Phase 2]

  Phase 2 neoadjuvant trial evaluating ribociclib with letrozole in locally advanced, ER-positive, HER2-negative breast cancer has completed.

• CLINICAL_TRIALS trial_result · 2024-01-31
  Clinical Trial Update: Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER) [Phase 2]

  Phase 2 neoadjuvant trial evaluating dalpiciclib with aromatase inhibitors in Luminal B/HER2-negative breast cancer.

• CLINICAL_TRIALS trial_result · 2022-03-15
  Clinical Trial Update: Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women [Phase 2]

  Phase 2 trial evaluating letrozole plus palbociclib as neoadjuvant therapy for postmenopausal women with stage II-IIIA luminal breast cancer…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-08-01
  Clinical Trial Update: Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) [Phase 2]

  Phase 2 GENEVIEVE trial comparing cabazitaxel to weekly paclitaxel as neoadjuvant therapy in specific breast cancer subtypes to assess effic…